Patient Advocacy and Engagement Lead, Congenica

Dr Charles Steward is the Patient Advocacy and Engagement Lead at Congenica. He has more than 26 years’ experience working with the human genome on the Wellcome Genome Campus, Cambridge UK. He spent 22 years at the Wellcome Sanger Institute, which is where he did his PhD. During this time, Dr Steward was a senior member of the Human and Vertebrate Analysis and Annotation team where he led the initial gene analysis and annotation for human chromosome 10, which was published in Nature in 2004. As a result of his daughter suffering from a catastrophic form of epilepsy called West syndrome, he established an international collaboration including Ensembl, Epilepsy Society and Cambridge University to reinvestigate the structure of epilepsy-associated genes and their transcript structures. Dr Steward he has led the Congenica epilepsy genomics initiative since 2016, which has included a collaboration with Epilepsy Society using whole genome sequencing of patients who have experienced sudden unexpected death in epilepsy (SUDEP). Dr Steward has over 12 years’ international teaching experience with the Wellcome Trust Advanced Courses and lectures on the Genomic Medicine Masters’ degree course for the NHS at King’s College London and the University of Cambridge. He has numerous publications, 20 of which are in Nature-associated journals.


16 November 2021